01 5-Amino-1MQ 5-Amino-1MQ is a research peptide that has been studied in the context of metabolic, mitochondrial signaling. Investigations focus on its interactions with NNMT and related downstream pathways.
NNMT Metabolic Mitochondrial
02 Adipotide (FTPP) Adipotide (FTPP) is a research peptide that has been studied in the context of metabolic, proapoptotic signaling. Investigations focus on its interactions with Prohibitin and related downstream pathways.
Prohibitin Metabolic Proapoptotic
03 AOD-9604 AOD-9604 is a research peptide that has been studied in the context of metabolic, aesthetics signaling. Investigations focus on its interactions with HGH Lipolytic Fragment (177-191) and related downstream pathways.
HGH Lipolytic Fragment (177-191) Metabolic Aesthetics
04 Cagrilintide Cagrilintide is a research peptide that has been studied in the context of satiety, metabolic signaling. Investigations focus on its interactions with Amylin and related downstream pathways.
Amylin Satiety Metabolic
05 CagriSema (Cagrilintide + Semaglutide) CagriSema (Cagrilintide + Semaglutide) is a research peptide that has been studied in the context of incretin, metabolic, satiety signaling. Investigations focus on its interactions with GLP-1, Amylin and related downstream pathways.
GLP-1 Amylin Incretin Metabolic
06 Liraglutide Liraglutide is a research peptide that has been studied in the context of incretin, metabolic signaling. Investigations focus on its interactions with GLP-1 and related downstream pathways.
GLP-1 Incretin Metabolic
07 Mazdutide Mazdutide is a research peptide that has been studied in the context of incretin, metabolic, thermogenic signaling. Investigations focus on its interactions with GLP-1, Glucagon and related downstream pathways.
GLP-1 Glucagon Incretin Metabolic
08 Retatrutide Retatrutide is an investigational triple agonist of GLP-1, GIP, and glucagon receptors. Current research has explored its effects on appetite signaling, metabolic regulation, and body composition.
GLP-1 GIP Glucagon Incretin Metabolic
09 Semaglutide Semaglutide is a long-acting GLP-1 receptor agonist studied for its effects on glycemic regulation, appetite signaling, and body composition. It is one of the most extensively researched incretin-class molecules.
GLP-1 Incretin Metabolic
10 Survodutide Survodutide is a research peptide that has been studied in the context of incretin, metabolic, thermogenic signaling. Investigations focus on its interactions with GLP-1, Glucagon and related downstream pathways.
GLP-1 Glucagon Incretin Metabolic